Cargando…

Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”

Detalles Bibliográficos
Autores principales: Li, Xiaoqing, Sun, Lan, Stucky, Andres, Tu, Lingli, Cai, Jin, Chen, Xuelian, Wu, Zhongjun, Jiang, Xuhong, Li, Shengwen Calvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947584/
https://www.ncbi.nlm.nih.gov/pubmed/35328170
http://dx.doi.org/10.3390/diagnostics12030617
_version_ 1784674474815127552
author Li, Xiaoqing
Sun, Lan
Stucky, Andres
Tu, Lingli
Cai, Jin
Chen, Xuelian
Wu, Zhongjun
Jiang, Xuhong
Li, Shengwen Calvin
author_facet Li, Xiaoqing
Sun, Lan
Stucky, Andres
Tu, Lingli
Cai, Jin
Chen, Xuelian
Wu, Zhongjun
Jiang, Xuhong
Li, Shengwen Calvin
author_sort Li, Xiaoqing
collection PubMed
description
format Online
Article
Text
id pubmed-8947584
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89475842022-03-25 Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364” Li, Xiaoqing Sun, Lan Stucky, Andres Tu, Lingli Cai, Jin Chen, Xuelian Wu, Zhongjun Jiang, Xuhong Li, Shengwen Calvin Diagnostics (Basel) Reply MDPI 2022-03-02 /pmc/articles/PMC8947584/ /pubmed/35328170 http://dx.doi.org/10.3390/diagnostics12030617 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Reply
Li, Xiaoqing
Sun, Lan
Stucky, Andres
Tu, Lingli
Cai, Jin
Chen, Xuelian
Wu, Zhongjun
Jiang, Xuhong
Li, Shengwen Calvin
Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”
title Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”
title_full Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”
title_fullStr Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”
title_full_unstemmed Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”
title_short Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”
title_sort reply to schramm, l. comment on “li et al. bdp1 variants i1264m and v1347m significantly associated with clinical outcomes of pediatric neuroblastoma patients imply a new prognostic biomarker: a 121-patient cancer genome study. diagnostics 2021, 11, 2364”
topic Reply
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947584/
https://www.ncbi.nlm.nih.gov/pubmed/35328170
http://dx.doi.org/10.3390/diagnostics12030617
work_keys_str_mv AT lixiaoqing replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364
AT sunlan replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364
AT stuckyandres replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364
AT tulingli replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364
AT caijin replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364
AT chenxuelian replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364
AT wuzhongjun replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364
AT jiangxuhong replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364
AT lishengwencalvin replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364